• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 PM/Scl 抗体在系统性硬化症中的流行率和意义。

The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis.

机构信息

Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.

出版信息

Ann Agric Environ Med. 2021 Mar 18;28(1):189-192. doi: 10.26444/aaem/127801. Epub 2020 Sep 28.

DOI:10.26444/aaem/127801
PMID:33775087
Abstract

INTRODUCTION

Anti-PM/Scl (a-PM/Scl) antibodies are found in different systemic autoimmune diseases such as polymyositis, dermatomyositis, systemic sclerosis (SSc) and overlap syndromes. According to literature, they are detected in approx. 2% of SSc patients, but their presence is more common in SSc with myositis overlap.

OBJECTIVE

The aim of the study was to assess the prevalence of a-PM/Scl in patients with SSc and to identify differences in the clinical profile of the disease in patients with the presence of a-PM/Scl.

MATERIAL AND METHODS

The study was performed on 126 European Caucasian SSc patients (98 females and 28 males) hospitalized consecutively in the Department of Rheumatology and Connective Tissue Diseases. The study group was analyzed for the potential presence of a-PM/Scl using a commercial test - EUROLINE Systemic Sclerosis Profile. The detection and interpretation were carried out electronically using the specific Euroimmun - EUROLineScan programme. The subtype of SSc, incidence of internal organ involvement and serological profile were determined in the entire group. Due to the presence of a-PM/Scl, patients were divided into two groups: a-PM/Scl (+) SSc - 22 patients and a-PM/Scl (-) SSc - 104 patients.

RESULTS

A-PM/Scl was detected in 22/126 patients with SSc (17.5%). A strong correlation was found between a-PM/Scl and myalgia or myositis (p = 0.0379), hand joints contractures (p = 0.0002) and the prevalence of overlap syndrome (p = 0.0142). There were no relationships between the presence of a-PM/Scl and subtypes of SSc, other organ involvement, digital ulcers or calcinosis.

CONCLUSIONS

Anti-PM/Scl antibodies are fairly common in patients with systemic sclerosis. In SSc, anti-PM/Scl antibodies are frequently associated with myalgia or myositis, hand joint contractures and an overlap syndrome.

摘要

简介

抗 PM/Scl(a-PM/Scl)抗体存在于多种自身免疫性疾病中,如多发性肌炎、皮肌炎、系统性硬皮病(SSc)和重叠综合征。根据文献报道,它们约存在于 2%的 SSc 患者中,但在伴有肌炎重叠的 SSc 患者中更为常见。

目的

本研究旨在评估 SSc 患者中 a-PM/Scl 的患病率,并确定存在 a-PM/Scl 的患者疾病临床特征的差异。

材料和方法

本研究纳入了 126 名连续住院于风湿病和结缔组织疾病科的欧洲白种人 SSc 患者(98 名女性和 28 名男性)。使用商业试剂盒 EUROLINE 系统性硬皮病谱对研究组进行 a-PM/Scl 的潜在存在情况进行分析。使用特定的 Euroimmun-EUROLineScan 程序进行电子检测和解释。确定了整个组的 SSc 亚型、内脏器官受累发生率和血清学特征。由于存在 a-PM/Scl,患者被分为两组:a-PM/Scl(+)SSc-22 名患者和 a-PM/Scl(-)SSc-104 名患者。

结果

在 126 名 SSc 患者中发现了 22 名(17.5%)存在 a-PM/Scl。a-PM/Scl 与肌痛或肌炎(p=0.0379)、手部关节挛缩(p=0.0002)和重叠综合征的患病率(p=0.0142)之间存在强烈相关性。a-PM/Scl 与 SSc 亚型、其他器官受累、手指溃疡或钙沉积之间没有关系。

结论

抗 PM/Scl 抗体在系统性硬皮病患者中相当常见。在 SSc 中,抗 PM/Scl 抗体常与肌痛或肌炎、手部关节挛缩和重叠综合征相关。

相似文献

1
The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis.抗 PM/Scl 抗体在系统性硬化症中的流行率和意义。
Ann Agric Environ Med. 2021 Mar 18;28(1):189-192. doi: 10.26444/aaem/127801. Epub 2020 Sep 28.
2
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.抗PM/Scl-75和PM/Scl-100抗体是系统性硬化症患者不同亚组的独立标志物。
Arthritis Res Ther. 2009;11(1):R22. doi: 10.1186/ar2614. Epub 2009 Feb 16.
3
Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.除了肌炎和硬皮病之外,在患有各种系统性自身免疫性疾病的日本患者中发现了抗PM/Scl抗体。
Arthritis Res Ther. 2015 Mar 11;17(1):57. doi: 10.1186/s13075-015-0573-x.
4
Anti-PM-Scl antibody in patients with systemic sclerosis.抗 PM-Scl 抗体在系统性硬化症患者中的应用。
Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S12-6. Epub 2012 May 29.
5
Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.抗 PM/Scl 抗体在系统性硬化症中的临床和血清学相关性:763 例患者的多中心研究。
Arthritis Rheumatol. 2014 Jun;66(6):1608-15. doi: 10.1002/art.38428.
6
Serological profile of patients with systemic sclerosis.系统性硬化症患者的血清学特征
Postepy Hig Med Dosw (Online). 2014 Aug 18;68:987-91. doi: 10.5604/17322693.1117543.
7
Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.硬皮病中的抗 PM/Scl-100 和抗 RNA 聚合酶 III 抗体。
Clin Chim Acta. 2010 Jul 4;411(13-14):965-71. doi: 10.1016/j.cca.2010.03.018. Epub 2010 Mar 25.
8
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.系统性硬化症特异性抗体:新型和经典生物标志物。
Clin Rev Allergy Immunol. 2023 Jun;64(3):412-430. doi: 10.1007/s12016-022-08946-w. Epub 2022 Jun 18.
9
Overlap syndromes in systemic sclerosis.系统性硬化症中的重叠综合征。
Postepy Dermatol Alergol. 2018 Jun;35(3):246-250. doi: 10.5114/ada.2018.72662. Epub 2018 Jun 18.
10
Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.无临床多肌炎或硬皮病患者体内的抗PM/Scl自身抗体。
J Rheumatol. 1996 Oct;23(10):1729-33.

引用本文的文献

1
Overlapping Connective Tissue Disease-Polymyositis and Diffuse Systemic Scleroderma: A Case Report.重叠性结缔组织病-多发性肌炎与弥漫性系统性硬化症:一例报告
Clin Med Insights Arthritis Musculoskelet Disord. 2025 Sep 2;18:11795441251370380. doi: 10.1177/11795441251370380. eCollection 2025.
2
The Art of Interpreting Antinuclear Antibodies (ANAs) in Everyday Practice.日常实践中抗核抗体(ANA)的解读技巧
J Clin Med. 2025 Jul 28;14(15):5322. doi: 10.3390/jcm14155322.
3
Patients with anti-PM/Scl-positive and idiopathic inflammatory myopathy resemble anti-synthetase syndrome.
抗PM/Scl阳性且患有特发性炎性肌病的患者类似于抗合成酶综合征。
Adv Rheumatol. 2025 Feb 14;65(1):9. doi: 10.1186/s42358-025-00441-y.
4
Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic players.系统性硬化症中的自身抗体:从疾病旁观者到致病参与者。
J Transl Autoimmun. 2025 Jan 21;10:100272. doi: 10.1016/j.jtauto.2025.100272. eCollection 2025 Jun.
5
Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies.自身免疫性炎性肌病相关自身抗体及相关生物标志物的最新研究进展。
Curr Opin Rheumatol. 2023 Nov 1;35(6):383-394. doi: 10.1097/BOR.0000000000000957. Epub 2023 Jul 27.
6
Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics.检查点抑制剂相关的硬皮病及硬皮病样疾病
Pharmaceuticals (Basel). 2023 Feb 8;16(2):259. doi: 10.3390/ph16020259.
7
Atrophic Gastritis and Autoimmunity: Results from a Prospective, Multicenter Study.萎缩性胃炎与自身免疫:一项前瞻性多中心研究的结果
Diagnostics (Basel). 2023 Apr 30;13(9):1599. doi: 10.3390/diagnostics13091599.
8
Autoantibodies and Clinical Correlations in Polish Systemic Sclerosis Patients: A Cross-Sectional Study.波兰系统性硬化症患者的自身抗体与临床相关性:一项横断面研究。
J Clin Med. 2023 Jan 13;12(2):657. doi: 10.3390/jcm12020657.
9
The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review.硬皮病中平滑肌、横纹肌和心肌的参与:综述。
Int J Mol Sci. 2022 Oct 9;23(19):12011. doi: 10.3390/ijms231912011.
10
Predicting the Progression of Very Early Systemic Sclerosis: Current Insights.预测极早期系统性硬化症的进展:当前见解
Open Access Rheumatol. 2022 Sep 15;14:171-186. doi: 10.2147/OARRR.S285409. eCollection 2022.